share_log
Reuters ·  Mar 18 10:51
Arrowhead Pharmaceuticals : Leerink Partners Cuts Target Price to $22 From $24
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 368

Recommended

Write a comment